Eventeeka
Conferences

US Market Access and Commercial Execution

Workshop for healthtech and life science companies preparing for the US market

Event artwork: US Market Access and Commercial Execution

In short

An interactive workshop for healthtech and life science companies preparing to enter or expand in the US market. It focuses on commercializing value, reimbursement, pricing, purchasing decisions, partnerships, and contract structures that support revenue. The programme includes real-world examples, practical exercises, case studies, discussion, and optional 1:1 sparring with Elizabeth Jennings.

Summary by Eventeeka from the organizer’s announcement. The original text follows below.

26 November 2026 – 27 November 2026, Thursday · 09:00–16:00 (2026-11-27) · Free · EN

Tehnopol, room Saturn, Teaduspargi 6/1, 12618 Tallinn, Harju maakond ↗

Tickets and sign-up

Turning US market opportunity into commercially viable revenueThe US healthcare market offers enormous opportunities for European healthtech and life science companies. But success requires more than understanding regulatory pathways, identifying potential customers, or demonstrating clinical value.

The real challenge is translating that value into a commercially sustainable business: who will pay, why will they pay, what must happen before a purchase, and how can companies reach revenue without exhausting their capital?

Following the Health3-2-1 workshops hosted by Swecare in Stockholm, Lund, and Business Turku earlier this year, Tehnopol is bringing the third installment of the series to Tallinn.

Led by Elizabeth Jennings, Managing Partner of Venture Atlas Labs, this advanced, interactive workshop moves beyond US market-entry fundamentals into the economics, commercial agreements, institutional purchasing decisions, and partnerships that determine whether companies can actually generate revenue.

It is designed for companies actively preparing to enter or expand in the US, as well as those evaluating whether their commercial assumptions are realistic.

Previous participation is not required. The workshop builds on earlier sessions while providing the context necessary for newcomers.

The workshop uses real-world examples, practical exercises, commercial case studies, and discussion rather than relying on theoretical market-entry frameworks.

What will we cover? Thursday, 26 November — Commercializing for value and capital efficiency

How US healthcare organizations evaluate clinical, financial, and operational value — and why these priorities frequently conflict.

Identifying the real economic buyer and selecting the right initial customer segment.

Understanding reimbursement mechanics, payer economics, coding, and the difference between reimbursement and revenue.

Structuring value-based agreements, shared savings, and outcome-linked contracts.

Building defensible pricing models based on realizable customer value.

Navigating hospital procurement, value analysis committees, and the internal approval process.

Friday, 27 November — Strategic partnerships and commercial execution

Evaluating distributors, strategic partners, licensing arrangements, and alternative channels to market.

Structuring partner economics, performance commitments, and commercially protective contract terms.

Moving from initial interest and pilots toward paid institutional adoption.

Navigating commercial claims, regulatory constraints, and compliance risks.

Building a focused six-month US commercialization plan.

Individual company sparring

Friday afternoon will be reserved for pre-booked 1:1 sessions with Elizabeth to discuss company-specific market entry challenges, commercial assumptions, positioning, partnerships, and next steps.

Meet the expertElizabeth Jennings is Managing Partner at Venture Atlas Labs and has 16 years of experience in international healthcare technology commercialization and investment, spanning 28 countries.

Her background includes startup and executive leadership, venture investment, healthcare economics, policy, and advisory work with international innovation ecosystems. She has authored three guidebooks on US healthcare commercialization and economics for Denmark and New Zealand and regularly works with Nordic and Baltic healthtech companies preparing for US expansion.

Elizabeth previously led the Health3-2-1 workshops in Stockholm, Lund, and Turku in 2026.

Practical informationDates: 26–27 November 2026

Location: Tehnopol, Tallinn

Format: In-person, English-language workshop with interactive instruction, exercises, and individual sparring

Organized by: Tehnopol within the Health3-2-1 programme, in collaboration with Swecare and Business Turku.

Would you like to book a 1:1 session with Jennings? Please contact Project Manager Mariann Uudmäe at mariann.uudmae@tehnopol.ee.

Coming up

Browse everything happening →
Tickets and sign-up